FDA 采用真实世界证据作为主要或唯一证据用于支持医疗器械不同注册目的与注册路径的特征分析

China Food Drug Administration ›› 2024, Vol. 0 ›› Issue (10) : 76-85.

PDF(1545 KB)
PDF(1545 KB)
China Food Drug Administration ›› 2024, Vol. 0 ›› Issue (10) : 76-85. DOI: 10.3969/j.issn.1673-5390.2024.10.009

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1545 KB)

Accesses

Citation

Detail

Sections
Recommended

/